August 2017 - Volume 28 - Issue 7

  • Mels Sluyser, PhD
  • 0959-4973
  • 1473-5741
  • 10 / year
  • 142 of 217 Oncology
    136 of 256 Pharmacology & Pharmacy
  • 2.320

Current Issue Highlights



Prevalence and influence on outcome of HER2/neu, HER3 and NRG1 expression in patients with metastatic colorectal cancer

Stahler, Arndt; Heinemann, Volker; Neumann, Jens; More

Anti-Cancer Drugs . 28(7):717-722, August 2017.


Dexrazoxane added to doxorubicin-based adjuvant chemotherapy of breast cancer: a retrospective cohort study with a comparative analysis of toxicity and survival

Tahover, Esther; Segal, Amiel; Isacson, Rut; More

Anti-Cancer Drugs . 28(7):787-794, August 2017.